Hetero Drugs launches bio similar drug of Rituximab
Hetero Drugs has launched a bio similar drug of Roche ‘s Rituximab, under the brand name Maball in Indian market. Rituximab is a monoclonal antibody […]
Formulations
Ajanta Pharma receives final approval for Monelukast
Ajanta Pharma has received final approval for its three ANDAs (Abbreviated New Drug Application) by USFDA for Montelukast tablets in the strength of 10 mg, […]
Lupin acquires Zao Biocom of Russia
Lupin today has acquired Zao Biocom, a generic pharma company in Russia to make its foray into the Russian market. It is estimated that Russia […]
Intas Pharma plans expansion programme
Intas Pharmaceuticals planning an expansion programme at its bulk drug manufacturing unit at Matoda village in Ahmedabad district of Gujarat. The project will come up […]
Aurobindo Pharma receives USFDA approval for Ibandronate Sodium Injection and Omeprazole
Aurobindo Pharma Ltd has received approval from the US Food & Drug Administration (USFDA) to manufacture and market Ibandronate Sodium Injection used in treatment of […]
Emcure Pharmaceuticals Hingenwadi plant receives USFDA ban
Emcure Pharmaceuticals had been barred exports from its Hinjewadi manufacturing plant in the western state of Maharashtra. According to USFDA, the manufacturing plant does not […]
Zydus Cadila receives USFDA approval for Pyridostigmine Bromide
Zydus Cadila has received final approval from the USFDA to market Pyridostigmine Bromide Tablets USP, 60 mg. The tablets are used in treatment of neurological […]